<SEC-DOCUMENT>0001213900-25-060005.txt : 20250701
<SEC-HEADER>0001213900-25-060005.hdr.sgml : 20250701
<ACCEPTANCE-DATETIME>20250701092639
ACCESSION NUMBER:		0001213900-25-060005
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20250701
FILED AS OF DATE:		20250701
DATE AS OF CHANGE:		20250701

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Inspira Technologies OXY B.H.N. Ltd
		CENTRAL INDEX KEY:			0001837493
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40303
		FILM NUMBER:		251094411

	BUSINESS ADDRESS:	
		STREET 1:		HATIDHAR 2
		STREET 2:		11TH FLOOR
		CITY:			RA'ANANA
		STATE:			L3
		ZIP:			4366504
		BUSINESS PHONE:		972-9-9664488

	MAIL ADDRESS:	
		STREET 1:		HATIDHAR 2
		STREET 2:		11TH FLOOR
		CITY:			RA'ANANA
		STATE:			L3
		ZIP:			4366504
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea0247647-6k_inspira.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO RULE 13a-16 OR 15d-16</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the Month of: July 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Commission File Number: 001-40303</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Inspira Technologies Oxy B.H.N. Ltd.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Translation of registrant&rsquo;s name into
English)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2 Ha-Tidhar St.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Ra&rsquo;anana 4366504, Israel</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Address of principal executive office)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#9746;&nbsp;Form 20-F&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9744;&nbsp;Form
40-F</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>CONTENTS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 1, 2025, Inspira Technologies
Oxy B.H.N. Ltd (the &ldquo;Registrant&rdquo;) increased the maximum aggregate offering price of its ordinary shares, no par value (the
&ldquo;Ordinary Shares&rdquo;) issuable under its Sales Agreement (the &ldquo;Sales Agreement&rdquo;) with A.G.P./Alliance Global Partners,
dated March 14, 2025, from $1,917,052 to $7,117,720. A copy of the opinion of Sullivan &amp; Worcester Tel-Aviv (Har-Even&amp; Co.) relating
to the legality of the issuance and sale of the Ordinary Shares that may be sold pursuant to the Sales Agreement is attached as Exhibit
5.1 hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Foreign Private Issuer
Report on Form 6-K is incorporated&nbsp;<FONT STYLE="background-color: white">by reference into the Registrant&rsquo;s Registration Statements
on Form F-3 (Registration No. </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/1837493/000121390022046430/ea164081-f3_inspiratech.htm"><FONT STYLE="background-color: white">333-266748</FONT></A>
<FONT STYLE="background-color: white">and&nbsp;</FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1837493/000121390025004023/ea0227763-f3_inspira.htm"><FONT STYLE="background-color: white">333-284308</FONT></A><FONT STYLE="background-color: white">)
and Form S-8 (Registration Nos. </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/1837493/000121390021044780/ea146415-s8_inspiratech.htm"><FONT STYLE="background-color: white">333-259057</FONT></A><FONT STYLE="background-color: white">,
</FONT><A HREF="http://www.sec.gov/Archives/edgar/data/1837493/000121390024023044/ea0201791-s8_inspira.htm"><FONT STYLE="background-color: white">333-277980</FONT></A>
and <A HREF="https://www.sec.gov/Archives/edgar/data/1837493/000121390025020699/ea0233153-s8_inspira.htm">333-285565</A><FONT STYLE="background-color: white">), filed with the Securities and Exchange Commission, to be a part thereof from the
date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; width: 9%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit&nbsp;No.</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 90%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>Description</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea024764701ex5-1_inspira.htm">Opinion of Sullivan &amp; Worcester Tel-Aviv (Har-Even &amp; Co.)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea024764701ex5-1_inspira.htm">Consent of Sullivan &amp; Worcester Tel-Aviv (Har-Even &amp; Co.) (contained in Exhibit 5.1)</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SIGNATURES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Inspira Technologies Oxy B.H.N. Ltd.</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: July 1, 2025</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Yafit Tehila</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yafit Tehila</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ea024764701ex5-1_inspira.htm
<DESCRIPTION>OPINION OF SULLIVAN & WORCESTER TEL-AVIV (HAR-EVEN & CO.)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right; background-color: white; text-indent: 0pt"><B>Exhibit
5.1</B></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="text-align: left; width: 40%; font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT="" STYLE="height: 66px; width: 155px"></TD>
    <TD STYLE="width: 30%"><B>Sullivan &amp; Worcester Tel Aviv </B> <BR>
28 HaArba&rsquo;a
St. HaArba&rsquo;a<BR>
 Towers North Tower, 35th Floor<BR>
 Tel-Aviv, Israel &nbsp;</TD>
    <TD STYLE="width: 10%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 20%">+972-747580480 <BR>
sullivanlaw.com</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: right; background-color: white">&nbsp;</P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right; background-color: white">July 1, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: right; background-color: white">&nbsp;</P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white">To:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; background-color: white">&nbsp;</P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white">Inspira Technologies Oxy B.H.N.
Ltd.</P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white">2 Ha-Tidhar St.</P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white">Ra&rsquo;anana, 4366504, Israel</P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white">&nbsp;</P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white">Re:&nbsp;<B><U>Registration
Statement on Form&nbsp;F-3</U></B></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white">&nbsp;</P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 40pt">We have acted as Israeli
counsel to Inspira Technologies Oxy B.H.N. Ltd., a company organized under the laws of the State of Israel (the &ldquo;<B>Company</B>&rdquo;),
in connection with its registration statement on Form F-3 (the &ldquo;<B>Registration Statement</B>&rdquo;), the prospectus included therein
and the related prospectus supplement (such prospectus, as supplemented by such prospectus supplement, the &ldquo;<B>Prospectus Supplement</B>&rdquo;)
filed with the Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;) under the Securities Act of 1933, as amended (the &ldquo;<B>Securities
Act</B>&rdquo;) with respect to the sale of up to $7,117,720 ordinary shares (the &ldquo;<B>Placement Shares</B>&rdquo;) of the Company,
no par value per share (the &ldquo;<B>Ordinary Shares</B>&rdquo;), from time to time pursuant to a sales agreement, dated as of March 14,
2025 (the &ldquo;<B>Sales Agreement</B>&rdquo;), entered into by and between the Company and A.G.P./Alliance Global Partners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 40pt">We have also acted as Israeli
counsel to the Company in connection with the Sales Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 40pt">In connection herewith, we
have examined the originals, or photocopies or copies, certified or otherwise identified to our satisfaction, of (i) the Registration
Statement; (ii) the Prospectus Supplement; (iii) the amended and restated articles of association of the Company, as currently in effect
(the &ldquo;<B>Articles</B>&rdquo;); (iv) minutes of meetings of the board of directors of the Company (the &ldquo;<B>Board</B>&rdquo;)
at which the filing of the Registration Statement and the actions to be taken in connection therewith, as well as the execution of the
Sales Agreement and the actions to be taken in connection therewith, were approved; and (v) such other corporate records, agreements,
documents and other instruments, and such certificates or comparable documents of public officials and of officers and representatives
of the Company as we have deemed relevant and necessary as a basis for the opinions hereafter set forth. We have also made inquiries of
such officers and representatives as we have deemed relevant and necessary as a basis for the opinions hereafter set forth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 40pt">In such examination, we have
assumed the genuineness of all signatures, the legal capacity of all natural persons, the authenticity of all documents submitted to us
as originals, the conformity to original documents of all documents submitted to us as certified, confirmed as photostatic copies and
the authenticity of the originals of such latter documents. We have also assumed the truth of all facts communicated to us by the Company
and that all minutes of meetings of the Board and the shareholders of the Company that have been provided to us are true and accurate
and have been properly prepared in accordance with the Articles and all applicable laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="text-align: left; width: 40%; font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT="" STYLE="height: 66px; width: 155px"></TD>
    <TD STYLE="width: 30%"><B>Sullivan &amp; Worcester Tel Aviv </B> <BR>
28 HaArba&rsquo;a
St. HaArba&rsquo;a<BR>
 Towers North Tower, 35th Floor<BR>
 Tel-Aviv, Israel &nbsp;</TD>
    <TD STYLE="width: 10%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 20%">+972-747580480 <BR>
sullivanlaw.com</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 40pt">Based upon and subject to
the foregoing, we are of the opinion that with respect to the Placement Shares, assuming that prior to the issuance of any of the Placement
Shares under the Sales Agreement, the price, number of Placement Shares and certain other terms of issuance with respect to any specific
placement notice delivered under the Sales Agreement will be authorized and approved by the Board or a pricing committee of the Board
in compliance with applicable Israeli law (for purposes of this paragraph, the &ldquo;<B>Authorizing Resolutions</B>&rdquo;), all corporate
proceedings necessary for the authorization, issuance and delivery of the Placement Shares shall have been taken and, upon issuance pursuant
to the terms of the Sales Agreement and in accordance with resolutions of the Board related to the offering of the Placement Shares, the
Placement Shares will be validly issued, fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 40pt">With respect to our opinion
as to the Placement Shares, we have assumed that, at the time of issuance and sale and to the extent any such issuance would exceed the
maximum share capital of the Company currently authorized, the number of Ordinary Shares that the Company is authorized to issue shall
have been increased in accordance with the Articles such that a sufficient number of Ordinary Shares are authorized and available for
issuance under the Articles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 40pt">We are members of the Israel
Bar in the State of Israel, and we do not express any opinion as to any matter relating to the laws of any jurisdiction other than the
laws of the State of Israel. This opinion is limited to the matters stated herein and no opinion is implied or may be inferred beyond
the matters expressly stated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 40pt">We consent to the filing of
this opinion as an exhibit on a Report of Foreign Private Issuer on Form 6-K of the Company being filed on the date hereof and to the
reference to our firm appearing under the caption &ldquo;Legal Matters&rdquo; and, if applicable, &ldquo;Enforceability of Civil Liabilities&rdquo;
in the Prospectus Supplement forming part of the Registration Statement. In giving this consent, we do not thereby admit that we are within
the category of persons whose consent is required under Section 7 of the Securities Act, the rules and regulations of the SEC promulgated
thereunder or Item 509 of the SEC&rsquo;s Regulation S-K under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 40pt">This opinion letter is rendered
as of the date hereof and we disclaim any obligation to advise you of facts, circumstances, events or developments that may be brought
to our attention after the effective date of this opinion that may alter, affect or modify the opinions expressed herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Very truly yours,</P>


<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%">/s/ Sullivan &amp; Worcester Tel-Aviv (Har-Even &amp; Co.)</TD>
    <TD STYLE="padding-bottom: 1pt; width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Sullivan &amp; Worcester Tel-Aviv (Har-Even &amp; Co.)</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "" 3,# 2(  A$! Q$!_\0
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M/NA?]?L7_H0KZ6^)?_).-=_Z]6H ^2*Z'P)_R/NA_P#7XE<]70^!/^1]T/\
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$ '__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
